Latest Videos |view all videos
Mayo Clinic physicians and researchers discuss how the molecular makeup of brain tumors can be used to identify five categories of gliomas, each with different clinical features and outcomes.
Robert D. Brown Jr., M.D., M.P.H., Neurology, David F. Kallmes, M.D., Radiology, Giuseppe Lanzino, M.D., Neurologic Surgery, and Alejandro A. Rabinstein, M.D., Neurology, at Mayo Clinic's campus in Rochester, Minnesota, discuss current ...
A Mayo Clinic study of people who received anesthesia for surgery after age 40 found no association between the anesthesia and the development of mild cognitive impairment later in life.
Giuseppe Lanzino, M.D., and Alejandro A. Rabinstein, M.D., discuss treatment of patients with subarachnoid hemorrhages that result from ruptured brain aneurysms. This condition, one of the most complex acute conditions encountered in medicine, ...
Prashanthi Vemuri, Ph.D., presents Cognitive Decline in the Elderly and the Role of Cognitive Reserve.
Ronald Petersen, M.D., Ph.D., discusses a new scoring system to help determine which elderly people may be at a higher risk of developing the memory and thinking problems that can lead to dementia.
By examining more than 3,600 postmortem brains, researchers at Mayo Clinic have found that the progression of dysfunctional tau protein drives the cognitive decline and memory loss seen in Alzheimer's disease.
Researchers at Mayo Clinic's campus in Florida have developed a mouse model that exhibits the features associated with the most common genetic form of ALS and frontotemporal dementia.
Michelle M. Mielke, Ph.D., presents Identifying and Translating Biomarkers for Neurodegenerative Diseases: Experience With Sphingolipids.